CRVL

CorVel Corp

Healthcare · USD

CRVL

Price

$54.46

+1.60%

Cap

$2.8B

Earnings

4/4 beat

30d Trend

+2%

CRVL
Loading chart data...
0 data pointsPowered by Brain47
52-week range13%
44.83119.57

Near 52-week lows — potential value or falling knife

Analyst consensus (1 analysts)
0 Strong Buy0 Buy1 Hold0 Sell0 Strong Sell

Consensus: Hold

Earnings history

Q3 2026

BEAT

0.47 vs

Q2 2026

BEAT

0.54 vs

Q1 2026

BEAT

0.52 vs

Q4 2025

BEAT

0.51 vs

VolatilityModerate

Key macro factors

·

Overall U.S. economic growth and business spending environment, as slower growth and potential cost-cutting measures by businesses could impact demand for CorVel's risk management and cost containment services. The IMF's downgraded global growth forecasts and the Middle East conflict threatening global growth suggest potential economic headwinds.

·

Health of the U.S. job market and employment rates. A robust job market, as indicated by the 'US Economy Adds 178,000 Jobs in March, Unemployment Dips to 4.3%', generally means more employed individuals, potentially leading to more workers' compensation claims, which is CorVel's core business.

·

Trends in healthcare costs and inflation. CorVel specializes in managing healthcare costs, and rising medical expenses would increase the value proposition of their cost containment solutions for clients. Recent earnings call summaries highlight rising medical costs as a key challenge in the workers' compensation market.

CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. The company applies technology, including artificial intelligence, machine learning, and natural language processing, to enhance the management of episodes of care and related healthcare costs.

Next earnings:2026-05-19

QUANT SCORE

Building intelligence for this stock. Brain47 needs a few days of price data to calculate technical indicators and generate a full quant score.

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.

CorVel Corp (CRVL) — Brain47 AI Score 44/100 | Analysis